Acc inhibitor combination therapy for the treatment of non-alcoholic fatty liver disease
AssigneeGilead Apollo, LLC
InventorsGeraldine C. Harriman, H. James Harwood, Rosana Kapeller-Libermann, William F. Westlin
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating, stabilizing or lessening the severity or progression of a non-alcoholic fatty liver disease using an ACC inhibitor alone or with one or more additional therapeutic agents.
Claims37
A method of treating, stabilizing, or lessening the severity or progression of a non-alcoholic fatty liver disease comprising administering to a patient in need thereof a composition comprising an ACC inhibitor.
A system for treating, stabilizing or lessening the severity of a non-alcoholic fatty liver disease, the system comprising an ACC inhibitor, in combination with one or more additional therapeutic agents.
A composition comprising an ACC inhibitor, one or more additional therapeutic agents, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
Dependencies are inferred from the claim text.